A weekly injection of semaglutide was safe and reduced by 31% of liver fat in patients with HIV and liver disease-as per data from a mid-stage study presented by the National Institutes of Health showed. Data from the study was first released on Monday at the
Four children born with HIV were able to live virus-free for more than a year after their HIV medication was paused, as per study funded by the National Institutes of Health. The results of the P1115 study were announced on Wednesday at the 2024 Conference on
Obesity and Metabolic Surgery Society of India (OSSI), the largest association of surgeons and integrated health members addressing obesity, announced the release of comprehensive guidelines for the “management of obesity”. These guidelines are a crucial response to the rising concerns around obesity in the Indian
